GRA Venture Fund

GRA Ventures is a private investment fund based in Atlanta, Georgia, established in 2009. It focuses on financing promising companies that emerge from Georgia's universities, primarily through seed, early-stage, and mid-stage investments. The fund is associated with the Georgia Research Alliance's commercialization arm and targets sectors such as technology, life sciences, manufacturing, and agriculture. Investors in GRA Ventures include the State of Georgia, as well as private individuals, corporations, and foundations, all aiming to foster innovation and economic growth within the state.

Connor Seabrook

Managing Director and Vice President

24 past transactions

Codoxo

Series B in 2022
Codoxo, also known as FraudScope, is a technology company that focuses on combating healthcare fraud, waste, and abuse through its artificial intelligence-based platform. Founded in 2016 and headquartered in Atlanta, Georgia, the company aims to enhance the allocation of healthcare funds by reducing fraudulent medical billing practices, which contribute to an estimated $272 billion in losses annually in the United States. Codoxo’s software platform employs advanced data analytics to detect, score, and rank suspicious claims, significantly improving upon traditional detection methods that often overlook fraud. The company's innovative Claims Intelligence technology, developed by researchers at the Georgia Institute of Technology, is capable of identifying evolving fraud schemes in real-time without relying on pre-existing fraud patterns. By utilizing data from the Centers for Medicare and Medicaid Services, Codoxo can proactively flag high-risk claims, thereby facilitating earlier interventions and ensuring healthcare resources are directed towards legitimate patient care.

Antios Therapeutics

Series B in 2021
Antios Therapeutics, Inc. is a biopharmaceutical company based in Atlanta, Georgia, founded in 2018. The company focuses on developing innovative therapies for viral diseases, particularly through its oral drug candidate, ATI-2173, aimed at treating patients infected with Hepatitis B and Hepatitis D viruses. With a leadership team that possesses extensive experience in the field, Antios Therapeutics is dedicated to advancing its research and development efforts toward potentially curative treatments for Hepatitis B virus infections.

Lucid Scientific

Seed Round in 2020
Lucid Scientific, Inc. is a biotechnology company based in Atlanta, Georgia, focused on enhancing drug discovery and biological research through its innovative real-time cellular activity monitors. The company develops a cell analyzer tool that measures oxygen consumption in standard multi-well plates using proprietary high-resolution optical oxygen sensors. This technology enables researchers in academic institutions and pharmaceutical companies to obtain continuous insights into cellular environments directly from incubators, facilitating more effective drug development and biological studies.

Codoxo

Series A in 2020
Codoxo, also known as FraudScope, is a technology company that focuses on combating healthcare fraud, waste, and abuse through its artificial intelligence-based platform. Founded in 2016 and headquartered in Atlanta, Georgia, the company aims to enhance the allocation of healthcare funds by reducing fraudulent medical billing practices, which contribute to an estimated $272 billion in losses annually in the United States. Codoxo’s software platform employs advanced data analytics to detect, score, and rank suspicious claims, significantly improving upon traditional detection methods that often overlook fraud. The company's innovative Claims Intelligence technology, developed by researchers at the Georgia Institute of Technology, is capable of identifying evolving fraud schemes in real-time without relying on pre-existing fraud patterns. By utilizing data from the Centers for Medicare and Medicaid Services, Codoxo can proactively flag high-risk claims, thereby facilitating earlier interventions and ensuring healthcare resources are directed towards legitimate patient care.

Apptega

Seed Round in 2020
Apptega Inc. develops cybersecurity management software solutions. It offers Apptega, a platform that enables users to build, manage, and report various cybersecurity functions through a series of applications, which connect with established frameworks and automatically share its data with other applications. The company’s platform also helps managed service providers to build and manage cybersecurity programs of their clients. It serves chief information officers and Fortune 1000 companies. Apptega Inc. was formerly known as Apptega, LLC. The company was incorporated in 2018 and is based in Atlanta, Georgia.

Acivilate

Seed Round in 2017
Acivilate, Inc., founded in 2014 and based in Atlanta, Georgia, is a majority woman-owned technology social enterprise that provides a cloud-based software as a service (SaaS) platform known as Pokket. This platform serves to connect justice agencies and human service providers with returning citizens, aiming to break the cycle of recidivism. By facilitating the synchronization of public and private social services case management, Acivilate's solution supports drug, problem-solving, and juvenile courts in sharing confidential data and managing rehabilitation programs. The company's focus is on addressing the challenges faced by individuals released from jail, thereby enhancing outcomes and interventions to promote successful reintegration into society.

Carbice

Seed Round in 2017
Carbice is a maker of Carbice Carbon, a product that lowers device temperatures and dissipates heat away from product packaging. It sets the standard for performance, reliability, and low-cost assembly within the world’s most important electronic, energy, and industrial products. Carbice Corporation was founded in January 2017 by Georgia Tech Professor Baratunde Cola, who first worked on thermal applications of advanced carbon materials in 2001 and later spent time as a test and development engineer at Intel; and co-founded by a team of leading Georgia Tech researchers in electronic device power management and product innovation. The company also has an office in London and one coming soon to Toulouse, France.

Codoxo

Seed Round in 2017
Codoxo, also known as FraudScope, is a technology company that focuses on combating healthcare fraud, waste, and abuse through its artificial intelligence-based platform. Founded in 2016 and headquartered in Atlanta, Georgia, the company aims to enhance the allocation of healthcare funds by reducing fraudulent medical billing practices, which contribute to an estimated $272 billion in losses annually in the United States. Codoxo’s software platform employs advanced data analytics to detect, score, and rank suspicious claims, significantly improving upon traditional detection methods that often overlook fraud. The company's innovative Claims Intelligence technology, developed by researchers at the Georgia Institute of Technology, is capable of identifying evolving fraud schemes in real-time without relying on pre-existing fraud patterns. By utilizing data from the Centers for Medicare and Medicaid Services, Codoxo can proactively flag high-risk claims, thereby facilitating earlier interventions and ensuring healthcare resources are directed towards legitimate patient care.

Axion Biosystems

Venture Round in 2016
Axion BioSystems, Inc. is a life science instrumentation company based in Atlanta, Georgia, specializing in multi-electrode array technology. This technology facilitates cellular information analysis for various sectors, including research, clinical applications, and drug discovery. The company offers a range of products, such as single-well systems, stimulating and recording channels, multi-well systems, and integrated circuits designed to eliminate stimulation artifacts. Among its key products are microelectrode array plates, the Axion BioSystems Integrated Studio (AxIS), and Lumos. Founded in 2007, Axion BioSystems aims to enhance the accessibility and quality of cellular data for scientific and medical advancements.

Quest Renewables

Seed Round in 2016
Quest Renewables, INC. designs, engineers, manufactures, and installs purpose-built solar canopy systems. The company was incorporated in 2013 and is based in Atlanta, Georgia.

StarMobile

Seed Round in 2015
StarMobile, Inc. provides cloud-based enterprise mobility solutions. It offers StarMobile, a cloud-based solution that allows customers to mobilize enterprise applications on any mobile device. The company was founded in 2012 and is based in Atlanta, Georgia.

Lumense

Series C in 2015
Lumense, Inc., founded in 2011 and based in Atlanta, Georgia, specializes in the development of real-time chemical and biological sensors utilizing optical interferometric sensor technology. The company emerged from $20 million in research conducted at Georgia Tech, from which it has exclusively licensed its core technology. Lumense's sensors are designed to detect impurities in gases and liquids, offering clients a proactive approach to contaminant management and recipe control. The company is focused on launching standard products in key areas while also collaborating with leading companies to create custom sensors tailored to specific industry needs.

Celtaxsys

Series D in 2015
Celtaxsys, Inc. operates as a clinical-stage drug discovery and development company that focuses on novel therapeutics to treat patients suffering from inflammatory diseases. It offers CTX-4430, a small-molecule drug that targets the enzyme Leukotriene A4 hydrolase in immune cells for the treatment of cystic fibrosis and moderately severe acne diseases. The company was founded in 2007 and is based in Atlanta, Georgia.

StarMobile

Seed Round in 2015
StarMobile, Inc. provides cloud-based enterprise mobility solutions. It offers StarMobile, a cloud-based solution that allows customers to mobilize enterprise applications on any mobile device. The company was founded in 2012 and is based in Atlanta, Georgia.

Soneter

Venture Round in 2014
Soneter, LLC specializes in manufacturing water flow and leak sensors and meters that provide real-time monitoring and alerts, primarily serving the multifamily housing sector. Established in 2010 and based in Atlanta, Georgia, the company focuses on protecting building owners and tenants from water damage due to undetected leaks. Through its innovative ultrasonic sensors and processing techniques, Soneter delivers crucial services such as water leak detection, sub-metering, and detailed usage information. This enables customers to gain insights into consumption patterns and anticipate potential hazards, thereby enhancing overall water management and safety. As of late 2016, Soneter operates as a subsidiary of Reliance Worldwide Corporation Limited.

Lumense

Series B in 2013
Lumense, Inc., founded in 2011 and based in Atlanta, Georgia, specializes in the development of real-time chemical and biological sensors utilizing optical interferometric sensor technology. The company emerged from $20 million in research conducted at Georgia Tech, from which it has exclusively licensed its core technology. Lumense's sensors are designed to detect impurities in gases and liquids, offering clients a proactive approach to contaminant management and recipe control. The company is focused on launching standard products in key areas while also collaborating with leading companies to create custom sensors tailored to specific industry needs.

StarMobile

Seed Round in 2013
StarMobile, Inc. provides cloud-based enterprise mobility solutions. It offers StarMobile, a cloud-based solution that allows customers to mobilize enterprise applications on any mobile device. The company was founded in 2012 and is based in Atlanta, Georgia.

Clearside Biomedical

Series A in 2013
Clearside Biomedical, Inc. is a biopharmaceutical company focused on developing and commercializing innovative treatments for serious eye diseases. Founded in 2011 and based in Alpharetta, Georgia, the company utilizes a proprietary ocular microinjection platform to deliver therapies directly to specific compartments of the eye, including the retina and choroid. Its lead product, XIPERE, is a suprachoroidal injectable suspension of triamcinolone acetonide, targeting macular edema associated with conditions such as uveitis and diabetic macular edema. Additionally, Clearside is advancing CLS-AX, an axitinib formulation for suprachoroidal injection. The company's novel SCS Microinjector allows for a non-surgical, repeatable procedure aimed at preserving and restoring vision in patients with sight-threatening eye diseases.

Urjanet

Series B in 2012
Urjanet, Inc. is a company that offers a cloud-based platform designed to streamline access to utility data. By connecting directly to utility providers, Urjanet acquires and normalizes utility bills and interval data, enabling organizations to automate data collection and enhance decision-making processes. Its offerings include a range of data-as-a-service solutions, such as automated access to utility bill data, granular measurements of energy consumption, and advanced metering infrastructure data. The platform also provides tools for users to submit utility credentials securely, as well as alerts for billing and consumption irregularities. Urjanet's data services support business intelligence, energy management, accounting, and procurement, helping organizations improve financial performance, energy efficiency, and sustainability. Founded in 2009 and headquartered in Atlanta, Georgia, with an additional office in Chennai, India, Urjanet aims to transform how organizations utilize utility data across various industries.

Pindrop

Seed Round in 2012
Pindrop Security, Inc. specializes in providing enterprise solutions to secure phone and voice communications, focusing on fraud prevention and customer verification. The company has developed patented technologies, including Phoneprinting, which analyzes phone calls to identify malicious behaviors and confirm legitimate callers. Additionally, Pindrop Express offers a risk-based authentication solution that validates customer phone numbers before calls reach contact centers. Its services are designed to combat various fraud tactics, such as caller ID spoofing and social engineering. Pindrop's solutions are utilized by numerous sectors, including finance, healthcare, insurance, retail, and travel, helping organizations detect fraudulent activities and authenticate callers efficiently. Established in 2011 and headquartered in Atlanta, Georgia, Pindrop is backed by prominent venture capital firms and plays a significant role in enhancing security and customer experience in voice interactions.

Clearside Biomedical

Series A in 2012
Clearside Biomedical, Inc. is a biopharmaceutical company focused on developing and commercializing innovative treatments for serious eye diseases. Founded in 2011 and based in Alpharetta, Georgia, the company utilizes a proprietary ocular microinjection platform to deliver therapies directly to specific compartments of the eye, including the retina and choroid. Its lead product, XIPERE, is a suprachoroidal injectable suspension of triamcinolone acetonide, targeting macular edema associated with conditions such as uveitis and diabetic macular edema. Additionally, Clearside is advancing CLS-AX, an axitinib formulation for suprachoroidal injection. The company's novel SCS Microinjector allows for a non-surgical, repeatable procedure aimed at preserving and restoring vision in patients with sight-threatening eye diseases.

Urjanet

Series A in 2011
Urjanet, Inc. is a company that offers a cloud-based platform designed to streamline access to utility data. By connecting directly to utility providers, Urjanet acquires and normalizes utility bills and interval data, enabling organizations to automate data collection and enhance decision-making processes. Its offerings include a range of data-as-a-service solutions, such as automated access to utility bill data, granular measurements of energy consumption, and advanced metering infrastructure data. The platform also provides tools for users to submit utility credentials securely, as well as alerts for billing and consumption irregularities. Urjanet's data services support business intelligence, energy management, accounting, and procurement, helping organizations improve financial performance, energy efficiency, and sustainability. Founded in 2009 and headquartered in Atlanta, Georgia, with an additional office in Chennai, India, Urjanet aims to transform how organizations utilize utility data across various industries.

Damballa

Series D in 2011
Damballa specializes in advanced threat protection, focusing on the detection of active threats that evade conventional security measures. The company employs data science and machine learning techniques to identify successful infections and assess the risk posed by compromised devices, regardless of their operating system or threat vector. Damballa's solutions are designed to discover previously unknown threats, making the company a key player in cybersecurity. It safeguards nearly a billion endpoints across various sectors, including enterprises and major telecommunications providers. The firm also addresses issues related to botnet formation, providing essential safeguards against the misuse of Internet-enabled devices for harmful activities.

Damballa

Series C in 2010
Damballa specializes in advanced threat protection, focusing on the detection of active threats that evade conventional security measures. The company employs data science and machine learning techniques to identify successful infections and assess the risk posed by compromised devices, regardless of their operating system or threat vector. Damballa's solutions are designed to discover previously unknown threats, making the company a key player in cybersecurity. It safeguards nearly a billion endpoints across various sectors, including enterprises and major telecommunications providers. The firm also addresses issues related to botnet formation, providing essential safeguards against the misuse of Internet-enabled devices for harmful activities.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.